Company Profiles

driven by the PitchBook Platform

Juvaris BioTherapeutics

Description

Developer of adjuvanted vaccines and immunotherapeutics designed to treat infectious disease and cancer. The company's adjuvanted vaccines and immunotherapeutics enhance the effect of vaccines by increasing the quantity and quality of the immune response and reducing the amount of antigen required in the vaccine, enabling patients to access improved treatment and up-regulate the immune system.

2001

Founded

PRIVATE

Status

Conv. Debt

Latest Deal Type

$750k

Latest Deal Amount

$44.3M

Total Amount Raised

3

Investors

Description

Developer of adjuvanted vaccines and immunotherapeutics designed to treat infectious disease and cancer. The company's adjuvanted vaccines and immunotherapeutics enhance the effect of vaccines by increasing the quantity and quality of the immune response and reducing the amount of antigen required in the vaccine, enabling patients to access improved treatment and up-regulate the immune system.

Website:

www.juvaris.com

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Drug Discovery

Other Industries

Other Pharmaceuticals and Biotechnology

Primary Office

P.O. Box 208 Pleasanton, CA 94566United States
    Request a free trial to the PitchBook Platform
    You're viewing a free company profile from the PitchBook Platform. To explore Juvaris BioTherapeutics's full profile, request a free trial.

    Juvaris BioTherapeutics Valuation and Funding

    Request access
    Deal TypeDateAmountRaised to DatePost-ValStatusStage

    Juvaris BioTherapeutics Cap Table

    Stock# of Shares
    Authorized
    Par ValueDividend Rate (%)Original
    Issue Price
    LiquidationLiquidation
    Pref. Multiple
    Conversion
    Price
    % Owned

    Juvaris BioTherapeutics Investors (3)

    Request access
    Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
    Seat
    Contact
    Info
    CSU VenturesVenture CapitalMinority000 0000000 0000
    Kleiner Perkins Caufield & ByersVenture CapitalMinority000 0000000 0000
    SV Health InvestorsVenture CapitalMinority000 0000000 0000
    CSU Ventures Venture Capital
    Kleiner Perkins Caufield & Byers Venture Capital
    SV Health Investors Venture Capital

    Juvaris BioTherapeutics Executive Team (2)

    NameTitleBoard
    Seat
    Contact
    Info
    Grant PickeringPresident, Board Member & Chief Executive Officer
    Kimberlee GonzagaChief Financial Officer
    Grant Pickering President, Board Member & Chief Executive Officer
    Kimberlee Gonzaga Chief Financial Officer

    Juvaris BioTherapeutics Board Members (5)

    NameRepresentingRoleSinceContact
    Info
    Carol Brosgart MDSelfBoard Member000 0000
    Lewis Williams Ph.DSelfBoard Member000 0000
    Mario Rosati JDWilson Sonsini Goodrich & RosatiPartner000 0000
    Michael Ross Ph.DSV Health InvestorsManaging Partner, Biotechnology000 0000
    Thomas Monath MDSelfBoard Member000 0000
    Carol Brosgart MD Board Member Self
    Lewis Williams Ph.D Board Member Self
    Mario Rosati JD Partner Wilson Sonsini Goodrich & Rosati
    Michael Ross Ph.D Managing Partner, Biotechnology SV Health Investors
    Thomas Monath MD Board Member Self
    Request full access to PitchBook